An Overview of the Diagnosis and Management of Eosinophilic Esophagitis (Q26764785)

Prevalence of eosinophilic esophagitis in adults with food bolus obstruction of the esophagus

volume

7

0 references

issue

3

0 references

page(s)

e155

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

The esophageal biopsy "pull" sign: a highly specific and treatment-responsive endoscopic finding in eosinophilic esophagitis (with video).

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

Utility of a Noninvasive Serum Biomarker Panel for Diagnosis and Monitoring of Eosinophilic Esophagitis: A Prospective Study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

Transcriptome analysis of proton pump inhibitor-responsive esophageal eosinophilia reveals proton pump inhibitor-reversible allergic inflammation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

Development and validation of a symptom-based activity index for adults with eosinophilic esophagitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

Markers of eosinophilic inflammation for diagnosis of eosinophilic esophagitis and proton pump inhibitor-responsive esophageal eosinophilia: a prospective study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

Epidemiology of eosinophilic esophagitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

Efficacy, dose reduction, and resistance to high-dose fluticasone in patients with eosinophilic esophagitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

Esophageal eosinophilia is increased in rural areas with low population density: results from a national pathology database

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

Histopathology of eosinophilic esophagitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

Dietary elimination therapy is an effective option for adults with eosinophilic esophagitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

Desmoglein-1 regulates esophageal epithelial barrier function and immune responses in eosinophilic esophagitis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

Prevalence of eosinophilic esophagitis in the United States

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

Meta-analysis: the safety and efficacy of dilation in eosinophilic oesophagitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

Esophageal distensibility as a measure of disease severity in patients with eosinophilic esophagitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

The oesophageal string test: a novel, minimally invasive method measures mucosal inflammation in eosinophilic oesophagitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

The prevalence and diagnostic utility of endoscopic features of eosinophilic esophagitis: a meta-analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

Viscous topical is more effective than nebulized steroid therapy for patients with eosinophilic esophagitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

Patchy eosinophil distributions in an esophagectomy specimen from a patient with eosinophilic esophagitis: Implications for endoscopic biopsy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

Prevalence of esophageal eosinophilia varies by climate zone in the United States

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

Influence of race and gender on the presentation of eosinophilic esophagitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

Review article: oesophageal dilation in adults with eosinophilic oesophagitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

Routine screening for eosinophilic esophagitis in patients presenting with dysphagia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

Toward uniformity in the diagnosis of eosinophilic esophagitis (EoE): the effect of guidelines on variability of diagnostic criteria for EoE.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

Understanding eosinophilic esophagitis: the cellular and molecular mechanisms of an emerging disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

Manometric features of eosinophilic esophagitis in esophageal pressure topography.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

Observations on use of montelukast in pediatric eosinophilic esophagitis: insights for the future.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

Mechanical Properties of the Esophagus in Eosinophilic Esophagitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

The 'hygiene hypothesis' for autoimmune and allergic diseases: an update

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

A systematic review of the risk of perforation during esophageal dilation for patients with eosinophilic esophagitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

Esophageal dilation in eosinophilic esophagitis: effectiveness, safety, and impact on the underlying inflammation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

Correlation between eosinophilic oesophagitis and aeroallergens

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

Might the use of acid-suppressive medications predispose to the development of eosinophilic esophagitis?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

Seasonal distribution in newly diagnosed cases of eosinophilic esophagitis in adults.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

Dissociation between symptoms and histological severity in pediatric eosinophilic esophagitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

14 years of eosinophilic esophagitis: clinical features and prognosis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

Histopathologic features of eosinophilic esophagitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

Rapidly increasing prevalence of eosinophilic oesophagitis in Western Australia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

Anti-ulcer drugs promote IgE formation toward dietary antigens in adult patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

Molecular cloning of a novel human CC chemokine (Eotaxin-3) that is a functional ligand of CC chemokine receptor 3.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

Prospective assessment of the diagnostic utility of esophageal brushings in adults with eosinophilic esophagitis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

The optimal number of biopsy fragments to establish a morphologic diagnosis of eosinophilic esophagitis

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

De-novo onset of eosinophilic esophagitis after large volume allergen exposures

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

Pharmacologic profile of OC000459, a potent, selective, and orally active D prostanoid receptor 2 antagonist that inhibits mast cell-dependent activation of T helper 2 lymphocytes and eosinophils

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4822098

Eosinophilic oesophagitis in patients presenting with dysphagia--a prospective analysis.

31 May 2018

1 reference

https://api.crossref.org/works/10.1038%2FCTG.2016.4

Rapidly increasing incidence of eosinophilic esophagitis in a large cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCTG.2016.4

Esomeprazole induces upper gastrointestinal tract transmucosal permeability increase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCTG.2016.4

Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCTG.2016.4

Endoscopic appearance and location dictate diagnostic yield of biopsies in eosinophilic oesophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCTG.2016.4

The tug sign: an endoscopic feature of eosinophilic esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCTG.2016.4

Randomized controlled trial comparing aerosolized swallowed fluticasone to esomeprazole for esophageal eosinophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCTG.2016.4

Comparison of eotaxin-3 biomarker in patients with eosinophilic oesophagitis, proton pump inhibitor-responsive oesophageal eosinophilia and gastro-oesophageal reflux disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCTG.2016.4

Impact of Diagnostic Delay and Other Risk Factors on Eosinophilic Esophagitis Phenotype and Esophageal Diameter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCTG.2016.4

A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCTG.2016.4

Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCTG.2016.4

Efficacy and safety of oral budesonide suspension in pediatric patients with eosinophilic esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCTG.2016.4

Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCTG.2016.4

3-yr-follow-up of topical corticosteroid treatment for eosinophilic esophagitis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCTG.2016.4

Swallowed topical corticosteroids reduce the risk for long-lasting bolus impactions in eosinophilic esophagitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCTG.2016.4

Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCTG.2016.4

Oral viscous budesonide: a potential new therapy for eosinophilic esophagitis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCTG.2016.4

Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCTG.2016.4

Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCTG.2016.4

Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCTG.2016.4

Empiric 6-food elimination diet induced and maintained prolonged remission in patients with adult eosinophilic esophagitis: a prospective study on the food cause of the disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCTG.2016.4

Esophageal dilation in eosinophilic esophagitis: safety and predictors of clinical response and complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCTG.2016.4

Endoscopy in eosinophilic esophagitis: "feline" esophagus and perforation risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCTG.2016.4

Perforation of the esophagus after dilation treatment for dysphagia in a patient with eosinophilic esophagitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCTG.2016.4

An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCTG.2016.4

Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCTG.2016.4

Intravenous anti-IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCTG.2016.4

Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCTG.2016.4

Anti-eosinophil activity and clinical efficacy of the CRTH2 antagonist OC000459 in eosinophilic esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCTG.2016.4

Escalating incidence of eosinophilic esophagitis: A 20-year prospective, population-based study in Olten County, Switzerland

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCTG.2016.4

Role of barium esophagography in evaluating dysphagia

21 January 2018

1 reference

12 December 2020

Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula

1 reference

12 December 2020

Letter: PPI-responsive oesophageal eosinophilia - from initial scepticism to consistent prospective data

1 reference

12 December 2020

Four-food group elimination diet for adult eosinophilic esophagitis: A prospective multicenter study

1 reference

12 December 2020

Delay in Diagnosis of Eosinophilic Esophagitis Increases Risk for Stricture Formation in a Time-Dependent Manner

1 reference

12 December 2020

Atopic characteristics of adult patients with eosinophilic esophagitis

1 reference

12 December 2020

Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years

1 reference

12 December 2020

Race may play a role in the clinical presentation of eosinophilic esophagitis

1 reference

12 December 2020

Idiopathic eosinophilic esophagitis is associated with a TH2-type allergic inflammatory response

1 reference

12 December 2020

Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults

1 reference

12 December 2020

Proton Pump Inhibitors Partially Restore Mucosal Integrity in Patients With Proton Pump Inhibitor–Responsive Esophageal Eosinophilia but Not Eosinophilic Esophagitis

1 reference

12 December 2020

The Role of Allergy Evaluation in Adults With Eosinophilic Esophagitis

1 reference

12 December 2020

Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis

1 reference

12 December 2020

Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis

1 reference

12 December 2020

Eosinophilic esophagitis: a prevalent disease in the United States that affects all age groups

1 reference

12 December 2020

Elemental diet induces histologic response in adult eosinophilic esophagitis

1 reference

12 December 2020

Eosinophilic esophagitis: Escalating epidemiology?

1 reference

12 December 2020

Prevalence of eosinophilic esophagitis in an adult population undergoing upper endoscopy: a prospective study

1 reference

12 December 2020

Accuracy, safety, and tolerability of tissue collection by Cytosponge vs endoscopy for evaluation of eosinophilic esophagitis

1 reference

12 December 2020

Montelukast was inefficient in maintaining steroid-induced remission in adult eosinophilic esophagitis

1 reference

12 December 2020

Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial

1 reference

12 December 2020

Long-Term Budesonide Maintenance Treatment Is Partially Effective for Patients With Eosinophilic Esophagitis

1 reference

12 December 2020

The natural history of steroid-naïve eosinophilic esophagitis in adults treated with endoscopic dilation and proton pump inhibitor therapy over a mean duration of nearly 14 years

1 reference

12 December 2020

Prevalence and predictive factors of eosinophilic esophagitis in patients presenting with dysphagia: a prospective study

1 reference

12 December 2020

Identifiers

DOI

10.1038/CTG.2016.4

1 reference

release_gorews6vyncqxgw5yrje2qiy2a

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gorews6vyncqxgw5yrje2qiy2a

24 November 2022

mapped directly with Wikidata item

1 reference

1 reference

PubMed publication ID

26986655

1 reference